Combining Inotuzumab Ozogamicin (IO) with PARP Inhibitors, Olaparib and Talazoparib, Exerts Synergistic Cytotoxicity by Inhibiting the Repair of IO-Induced DNA Strand Breaks in IO-Resistant ALL Cells
BLOOD（2023）
Key words
Olaparib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined